Clinical Trials Logo
  1. Home
  2. Left Ventricular Dysfunction
  3. NCT04871126
  4. Details
NCT04871126 Clinical Trial

Predictive Value of Inflammatory Indexes and CHA2DS2-VASc Score for LVT in ANT-MI With Left Ventricular Dysfunction

Left Ventricular Dysfunction Clinical Trial

Official title:
Predictive Value of Inflammatory Indexes and CHA2DS2-VASc Score for Left Ventricular Thrombus in Acute Anterior Myocardial Infarction With Left Ventricular Dysfunction

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT04871126
Other study ID # CHA2DS2-VASc score
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 1, 2014
Est. completion date January 1, 2021

Study information
Verified date April 2021
Source Henan Provincial People's Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

To investigate the predictive value of inflammatory indexes and CHA2DS2-VASc score for anterior myocardial infarction (ANT-MI) with left ventricular thrombus(LVT) (LVT).

Description:

The clinical data were collected from 371consecutive patients with ANT-MI in our hospital from January 2014 to January 2021.As a result,totally 62 patients with LVT were selected as the experimental group and 186 patients with non-LVT as the control group .The observation indexes included baseline data, coronary angiography, disease course, laboratory examination and auxiliary examination.Patients with severe organic disease and having previous history of left ventricular aneurysm( LVA) and LVT were excluded.Data was analyzed by software SPSS 22.0 for statistical analysis,and the logistic regression model was established.A P<0.05 was considered statistically significant, and the risk factors of LVT formation were retrospectively analyzed.

Recruitment information / eligibility
Status Completed
Enrollment 371
Est. completion date January 1, 2021
Est. primary completion date January 1, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: acute anterior myocardial infarction with left ventricular dysfunction Exclusion Criteria: end-stage organic disease, thrombotic hematological disorders, previous anticoagulant use, and poor echogenicity

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• inflammatory indexes and CHA2DS2-VASc score
inflammatory indexes and CHA2DS2-VASc score

Locations
Country Name City State
n/a

Sponsors (1)
Lead Sponsor Collaborator
Henan Provincial People's Hospital

Outcome
Type Measure Description Time frame Safety issue
Primary the predictive of the inflammatory indexes and CHA2DS2-VASc score in LVT the logistic regression model was established between the indexes and LVT Day 1
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05529654 - IMpella-Protected cArdiaC Surgery Trial (IMPACT) N/A
Recruiting NCT04671966 - Sex Differences in Myocardial Steatosis Induced Left Ventricular Dysfunction Phase 4
Not yet recruiting NCT05188222 - Preoperative Maltodextrin's Effect on Cardiac Function in Cardiac Surgery Phase 4
Recruiting NCT04950218 - The Psoriasis Echo Study
Completed NCT01076920 - Mesenchymal Stem Cells and Myocardial Ischemia Phase 1/Phase 2
Completed NCT01128790 - Pilot Study of Remote Ischemic Preconditioning in Heart Failure N/A
Completed NCT04942353 - Effects of Home-based Exercise Rehabilitation on Healthcare Utilization in HeartMate 3 Patients N/A
Recruiting NCT05769036 - Conventional Biventricular Versus Left Bundle Branch Pacing on Outcomes in Heart Failure Patients N/A
Completed NCT03232736 - InterventiOn of Biventricular Pacemaker Function on ventrIcular Function Among Patients With LVAD's
Recruiting NCT04694092 - Landiolol for Rate Control in Decompensated Heart Failure Due to Atrial Fibrillation N/A
Completed NCT02013037 - The De-novo Use of Eculizumab in Presensitized Patients Receiving Cardiac Transplantation Phase 3
Completed NCT01609738 - Left Ventricular Septum Pacing in Patients by Transvenous Approach Through the Inter-ventricular Septum Phase 1/Phase 2
Completed NCT00551681 - Effects of Left Ventricular Pacing Optimilization on Cardiac Perfusion, Contractile Force, and Clinical Performance in Patients With Ventricular Dysfunction and Heart Failure N/A
Not yet recruiting NCT04103008 - Left Ventricular Function After Primary Percutaneous Coronary Intervention: Role of Speckle Echocardiography
Completed NCT06197256 - Cardiac Dysfunction in Critically Ill Covid-19 Patients
Recruiting NCT05860504 - Acute Cardiac Dysfunction in Critical Illnes
Completed NCT03787810 - Left Ventricular Dysfunction in Critically Ill Patients
Completed NCT01093001 - Tricuspid Regurgitation Study Phase 4
Active, not recruiting NCT00461734 - PROTECT-PACE STUDY - The Protection of Left Ventricular Function During Right Ventricular Pacing N/A
Recruiting NCT04752293 - Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)